These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22718938)

  • 21. The Evaluation of the Performance of C. Diff Quik Chek Complete and Toxin A + B (Clostridium difficile) DUO Diagnostic Tests Compared with Toxigenic Culture in the Diagnosis of Clostridium difficile Infection.
    Yazisiz H; Özyurt ÖK; Öngüt G; Baysan BÖ; Dönmez L; Günseren F; Çolak D; Öğünç D
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridioides difficile laboratory diagnostic techniques: a comparative approach of rapid and molecular methods.
    Camargo TS; Junior MS; Camargo LFA; Biotto VP; Doi AM; Koga PCM; França CN; Martino MDV
    Arch Microbiol; 2021 May; 203(4):1683-1690. PubMed ID: 33459815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
    Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
    J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
    J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.
    Terveer EM; Crobach MJ; Sanders IM; Vos MC; Verduin CM; Kuijper EJ
    J Clin Microbiol; 2017 Feb; 55(2):403-411. PubMed ID: 27852676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1.
    Hoegh AM; Nielsen JB; Lester A; Friis-Møller A; Schønning K
    Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):1073-9. PubMed ID: 21938539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-step algorithm for the detection of Clostridium difficile from stool samples.
    Clark NS; Doughton MJ; Karas JA; Enoch DA
    J Hosp Infect; 2011 Sep; 79(1):95-6; author reply 96-7. PubMed ID: 21636166
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of 4 molecular assays as part of a 2-step algorithm for the detection of Clostridium difficile in stool specimens.
    Caulfield AJ; Bolster LaSalle CM; Chang YH; Grys TE
    Diagn Microbiol Infect Dis; 2018 May; 91(1):1-5. PubMed ID: 29428547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modifications of commercial toxigenic Clostridium difficile PCR resulting in improved economy and workflow efficiency.
    Munson E; Bilbo D; Paul M; Napierala M; Hryciuk JE
    J Clin Microbiol; 2011 Jun; 49(6):2279-82. PubMed ID: 21450967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection.
    Bruins MJ; Verbeek E; Wallinga JA; Bruijnesteijn van Coppenraet LE; Kuijper EJ; Bloembergen P
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3035-9. PubMed ID: 22706512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of clostridium difficile disease.
    Sharp SE; Ruden LO; Pohl JC; Hatcher PA; Jayne LM; Ivie WM
    J Clin Microbiol; 2010 Jun; 48(6):2082-6. PubMed ID: 20375230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of glutamate dehydrogenase (GDH) and toxin A/B rapid tests for Clostridioides (prev. Clostridium) difficile diagnosis in a university hospital in Minas Gerais, Brazil.
    Ramos CP; Lopes EO; Diniz AN; Lobato FCF; Vilela EG; Silva ROS
    Braz J Microbiol; 2020 Sep; 51(3):1139-1143. PubMed ID: 32367261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of two novel chemiluminescence immunoassays for the detection of Clostridium difficile glutamate dehydrogenase and toxin A&B.
    Blaich A; Frei R; Castellano C; Kiessling C; Geschke A; Rentsch KM; Egli A
    J Microbiol Methods; 2017 Apr; 135():63-65. PubMed ID: 28192156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens.
    LaSala PR; Ekhmimi T; Hill AK; Farooqi I; Perrotta PL
    J Clin Microbiol; 2013 Jan; 51(1):311-3. PubMed ID: 23135940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.
    Shin BM; Kuak EY; Lee EJ; Songer JG
    J Clin Microbiol; 2009 Sep; 47(9):2952-6. PubMed ID: 19625481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of a modified two-step algorithm using a combined glutamate dehydrogenase/toxin enzyme immunoassay and real-time PCR for the diagnosis of Clostridium difficile infection.
    Vasoo S; Stevens J; Portillo L; Barza R; Schejbal D; Wu MM; Chancey C; Singh K
    J Microbiol Immunol Infect; 2014 Feb; 47(1):75-8. PubMed ID: 22921803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of real-time PCR techniques to cytotoxigenic culture methods for diagnosing Clostridium difficile infection.
    Knetsch CW; Bakker D; de Boer RF; Sanders I; Hofs S; Kooistra-Smid AM; Corver J; Eastwood K; Wilcox MH; Kuijper EJ
    J Clin Microbiol; 2011 Jan; 49(1):227-31. PubMed ID: 20980562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory comparison between cell cytotoxicity neutralization assay and ultrasensitive single molecule counting technology for detection of Clostridioides difficile toxins A and B, PCR, enzyme immunoassays, and multistep algorithms.
    Sandlund J; Mills R; Griego-Fullbright C; Wagner A; Estis J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Nolan N; Bishop JJ; Todd J; Young S
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):20-24. PubMed ID: 31129008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antigen-positive toxin-negative enzyme immunoassay results for the diagnosis of toxigenic Clostridium difficile infection.
    Akamatsu Y; Morishita S; Chikumi H; Okamoto R; Okada K; Kitaura T; Miyake N; Yamaguchi K; Nakamoto M; Shimohiro H; Takata M; Yamasaki A; Burioka N; Shimizu E
    J Med Invest; 2018; 65(1.2):131-135. PubMed ID: 29593183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.